For MZ SR:
- director-General Department of Pharmacy and Drug Policy MUDr. Adam Hlôška
- director of the Department of Classification, Pricing and Drug Policy PharmDr. Rastislav Pullmann
- officer of the Department of Classification, Pricing and Drug Policy of MVDr. Erika Hanzelyová
For Sanofi Pasteur
- Mgr. Karel Torner
- Ing. Štefan Chrenko
The meeting took place at the request of Sanofi Pasteur, which asked for a meeting.
The meeting was opened by the Director General of the Department of Pharmacy and Drug Policy Dr. Adam Hlôška.
Sanofi Pasteur:
The reason for requesting a meeting was to communicate security the availability of Hepatitis A vaccine, as the marketing authorisation holder a competing medicinal product has been reported to be discontinued from delivery of the medicinal product to the State Institute for control of medicinal products. Currently in stock of the distribution company Intecpharma contains about 1,000 packs of 92296 Avaxim. Due to The epidemiological situation of the company increased the April order by 1000 pieces.
For MZ SR:
MZ SR expects the company to cover the needs of the hepatitis A vaccine and that If necessary, it will try to ensure the necessary quantities.
The sitting was closed by the Director-General of the Department of Pharmacy and Drug Policy Dr. Adam Hlôška.
|
She wrote: |
Mr Erika Hanzely |